Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,730.00
  • Today's Change8.50 / 0.49%
  • Shares traded341.45k
  • 1 Year change27.96%
  • Beta0.3501
Data delayed at least 20 minutes, as of Jun 18 2019 09:30 BST.
More ▼

Key statistics

Smith & Nephew PLC (SN.:LSE) set a new 52-week high during today's trading session when it reached 1,733.00. Over this period, the share price is up 27.07%.
52-week range
Today
1,242.50Oct 26 20181,733.00Jun 18 2019
Markit short selling activity
Low
Med
High
Open1,724.50
High1,733.00
Low1,718.00
Bid1,730.00
Offer1,730.50
Previous close1,721.50
Average volume1.98m
Shares outstanding874.74m
Free float871.49m
P/E (TTM)28.51
Market cap15.00bn GBP
EPS (TTM)0.6014
GBP
Annual div (ADY)27.66
GBX
Annual div yield (ADY)1.62%
Div ex-dateApr 04 2019
Div pay-dateMay 08 2019
Data delayed at least 20 minutes, as of Jun 18 2019 09:30 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Buy at 1,538.00 on 03 May 2019Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.